1 INTRODUCTION The prevalence of chronic kidney disease (CKD) continues to increase annually; by 2030, 14 per 100,000 people may die of CKD.[1] Owing to the lack of effective treatments, most CKD patients develop irreversible end-stage renal disease (ESRD), thus requiring renal replacement therapy (RRT) for survival.[2] In addition, similar to CKD, crosstalk between epithelial and inflammatory cells of autosomal dominant polycystic kidney disease (ADPKD) also results in ESRD.[3, 4] The poor...
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Guiling
Contact Guiling, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack